SteelPeak Wealth’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.3K | Hold |
7,600
| – | – | ﹤0.01% | 497 |
|
|
2025
Q1 | $33.6K | Hold |
7,600
| – | – | ﹤0.01% | 478 |
|
|
2024
Q4 | $53.2K | Sell |
7,600
-2,600
| -25% | -$18.2K | ﹤0.01% | 468 |
|
|
2024
Q3 | $148K | Sell |
10,200
-2,084
| -17% | -$30.2K | 0.01% | 439 |
|
|
2024
Q2 | $895K | Sell |
12,284
-1,510
| -11% | -$110K | 0.04% | 231 |
|
|
2024
Q1 | $817K | Buy |
13,794
+60
| +0.4% | +$3.55K | 0.04% | 236 |
|
|
2023
Q4 | $1.01M | Buy |
13,734
+35
| +0.3% | +$2.56K | 0.06% | 201 |
|
|
2023
Q3 | $532K | Buy |
13,699
+163
| +1% | +$6.33K | 0.03% | 242 |
|
|
2023
Q2 | $781K | Hold |
13,536
| – | – | 0.05% | 197 |
|
|
2023
Q1 | $880K | Sell |
13,536
-100
| -0.7% | -$6.5K | 0.06% | 172 |
|
|
2022
Q4 | $375K | Buy |
13,636
+170
| +1% | +$4.68K | 0.03% | 277 |
|
|
2022
Q3 | $393K | Hold |
13,466
| – | – | 0.03% | 286 |
|
|
2022
Q2 | $259K | Buy |
13,466
+125
| +0.9% | +$2.4K | 0.02% | 335 |
|
|
2022
Q1 | $1.08M | Buy |
13,341
+20
| +0.2% | +$1.62K | 0.06% | 171 |
|
|
2021
Q4 | $1.22M | Buy |
13,321
+5
| +0% | +$458 | 0.07% | 154 |
|
|
2021
Q3 | $1.67M | Buy |
13,316
+20
| +0.2% | +$2.5K | 0.11% | 116 |
|
|
2021
Q2 | $1.5M | Hold |
13,296
| – | – | 0.11% | 130 |
|
|
2021
Q1 | $2.01M | Hold |
13,296
| – | – | 0.16% | 100 |
|
|
2020
Q4 | $1.53M | Hold |
13,296
| – | – | 0.14% | 119 |
|
|
2020
Q3 | $1.03M | Buy |
13,296
+60
| +0.5% | +$4.64K | 0.11% | 137 |
|
|
2020
Q2 | $1.46M | Hold |
13,236
| – | – | 0.18% | 93 |
|
|
2020
Q1 | $1.45M | Hold |
13,236
| – | – | 0.23% | 91 |
|
|
2019
Q4 | $2.1M | Buy |
+13,236
| New | +$2.1M | 0.29% | 74 |
|